by [email protected] | May 5, 2023 | Hematology, Publication
Abstract Background: This study retrospectively compared annualized billed bleed rates (ABRb) in people with hemophilia A (PwHA) without inhibitors who switched from factor VIII (FVIII) prophylaxis to emicizumab. Research design and methods: A real-world comparison...
by [email protected] | Feb 14, 2023 | Cancer (blood), Hematology, Oncology, Publication
ABSTRACT Background: Primary myelofibrosis [PMF] is a myeloproliferative neoplasm associated with reduced overall survival (OS). Management strategies for PMF have evolved over the last two decades, including approval of ruxolitinib as the first Janus kinase 1...
by [email protected] | Nov 4, 2021 | Cancer (blood), Hematology, Publication
Authors: Srdan Verstovsek, Jingbo Yu, Robyn M Scherber, Sumit Verma, Christopher Dieyi, Chien-Cheng Chen, Shreekant Parasuraman Abstract This analysis examined trends in incidence and survival among US adults with myeloproliferative neoplasms, including...
by [email protected] | Oct 2, 2020 | Cancer (blood), Hematology, Publication
Abstract Authors: Shreekant Parasuraman, Jingbo Yu, Dilan Paranagama, Sulena Shrestha, Li Wang, Onur Baser, Robyn Scherber Background: Patients with polycythemia vera (PV) have a substantial risk of thrombotic events (TEs). The objective of the present analysis...
by [email protected] | Oct 17, 2019 | Cancer (blood), Hematology, Publication
Abstract Authors: Shreekant Parasuraman, Jingbo Yu, Dilan Paranagama, Sulena Shrestha, Li Wang, Onur Baser, Robyn Scherber Patients with polycythemia vera (PV) have a high incidence of thrombotic events (TEs), contributing to a greater mortality risk than the general...
by [email protected] | Sep 27, 2019 | Hematology, Hereditary Genetic, Publication
Abstract Authors: Nirmish Shah, Menaka Bhor, Lin Xie, Rashid Halloway, Steve Arcona, Jincy Paulose, Huseyin Yuce Background: This study aimed to evaluate sickle-cell disease (SCD) treatment patterns and economic burden among patients prescribed hydroxyurea (HU) in the...
